Development and Roll-Out of A Coronavirus Disease 2019 Clinical Pathway for Standardized Qualified Care in Public Hospitals in Koreaopen access
- Authors
- Kwak, Mi Young; Jo, Eun Young; Chin, BumSik; Park, Se Eun; Yim, Jun; Lee, Jung Eun; Jo, Kyung Eun; Kim, Yeon-Sook; Lee, Jeong Eun; Yoon, Young Kyung; Seo, Yu Bin; Jeong, Su Jin; Kang, Yu Min; Joo, Eun-Jeong; Yoon, Jong Hyun; Kim, Sun Bean; Kim, Ga Yeon; Kim, Min-Kyung
- Issue Date
- Jun-2022
- Publisher
- Korean Society of Infectious Diseases; Korean Society for Antimicrobial Therapy
- Keywords
- SARS-CoV-2; COVID-19; Pandemics; Clinical pathways; Hospitals, public
- Citation
- Infection and Chemotherapy, v.54, no.2, pp 353 - 359
- Pages
- 7
- Indexed
- SCOPUS
ESCI
KCI
- Journal Title
- Infection and Chemotherapy
- Volume
- 54
- Number
- 2
- Start Page
- 353
- End Page
- 359
- URI
- https://scholarworks.korea.ac.kr/kumedicine/handle/2021.sw.kumedicine/61225
- DOI
- 10.3947/ic.2022.0026
- ISSN
- 2093-2340
2092-6448
- Abstract
- Despite the coronavirus disease 2019 (COVID-19) vaccination roll-out, variant-related outbreaks have occurred repeatedly in Korea. Although public hospitals played a major role in COVID-19 patients' care, difficulty incorporating evolving COVID-19 treatment guidelines called for a clinical pathway (CP). Eighteen public hospitals volunteered, and a professional review board was created. CPs were formulated containing inclusion/exclusion criteria, application flow charts, and standardized order sets. After CP roll-out, key parameters improved, such as increased patient/staff five-point satisfaction scores (0.41/0.57) and decreased hospital stays (1.78 days)/medical expenses (17.5%). The CPs were updated consistently after roll-out as new therapeutics drugs were introduced and quarantine policies changed.
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - 2. Clinical Science > Department of Infectious Diseases > 1. Journal Articles
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.